MENU
+Compare
ATYR
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$3.61
Change
-$0.14 (-3.73%)
Capitalization
303.03M

ATYR aTyr Pharma Inc Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ATYR with price predictions
Jan 08, 2025

ATYR in downward trend: price may drop because broke its higher Bollinger Band on December 26, 2024

ATYR broke above its upper Bollinger Band on December 26, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 43 similar instances where the stock broke above the upper band. In of the 43 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ATYR moved out of overbought territory on January 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ATYR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATYR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 24, 2024. You may want to consider a long position or call options on ATYR as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ATYR just turned positive on December 24, 2024. Looking at past instances where ATYR's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ATYR crossed bullishly above the 50-day moving average on December 26, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATYR advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 149 cases where ATYR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATYR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.638) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ATYR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1000.000) is also within normal values, averaging (264.084).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATYR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ATYR is expected to report earnings to fall 2.17% to -22 cents per share on March 26

aTyr Pharma Inc ATYR Stock Earnings Reports
Q4'24
Est.
$-0.22
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of -23 cents, missing the estimate of -21 cents. With 670.15K shares outstanding, the current market capitalization sits at 303.03M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANTUX8.080.08
+1.00%
American Century Non-US IntrsVal Inv
JMIGX26.980.26
+0.97%
Jacob Discovery Fd Instl
FAPCX16.430.09
+0.55%
Fidelity Intl Cptl Apprec K6
JEPRX14.540.05
+0.35%
JPMorgan Equity Premium Income R6
GCINX13.830.04
+0.29%
Green Century MSCI Intl Indx Indvl Inv

ATYR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with FBIO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then FBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-3.73%
FBIO - ATYR
34%
Loosely correlated
-2.09%
VERV - ATYR
34%
Loosely correlated
+0.66%
MGTX - ATYR
33%
Loosely correlated
+5.56%
SER - ATYR
33%
Loosely correlated
+1.26%
CRSP - ATYR
33%
Poorly correlated
+0.57%
More